Ara
Toplam kayıt 6, listelenen: 1-6
Impact of aortic stiffness on the frequency of paroxysmal atrial fibrillation recurrences
(Taylor & Francis, 2015)
Background The relationship between arterial stiff ness (AS) and atrial fi brillation (AF) incidence is well-known. In this study we aimed to investigate the relationship between AS parameters and AF occurence as well as ...
Effect of pulmonary vein anatomy and pulmonary vein diameters on outcome of cryoballoon catheter ablation for atrial fibrillation
(Wiley, 2015)
BackgroundIn this study, we aimed to determine pulmonary vein (PV) variation patterns in patients undergoing cryoballoon ablation for atrial fibrillation (AF) and their impacts on procedural success and recurrence and also ...
Asymptomatic pulmonary embolism after ablation
(Karger, 2016)
Background: Pulmonary embolism (PE) is a life-threatening event with a broad presentation spectrum ranging from asymptomatic cases to sudden cardiac arrest. It is unclear if right atrial emboli cause PE in patients with ...
The relationship between the S-wave in lead 1 and recurrence of RVOT PVC ablation
(Churchill Livingstone Inc Medical Publishers, 2018)
Background: Radiofrequency catheter ablation (CA) is a common non-pharmacological treatment option for ventricular premature contractions (PVCs) originating from right ventricular outflow tract (RVOT). In this study, we ...
Evaluation of adult versus pediatric transesophageal echocardiography probe efficiency for guiding septal puncture during atrial fibrillation ablation
(Blackwell Publishing, 2015)
PurposeTransesophageal echocardiography (TEE) has a pivotal role in invasive cardiology practice in terms of guiding a variety of procedures. It is challenging to perform TEE examination with sedated patients due to ...
Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure
(Elsevier, 2015)
Treatment of supraventricular tachycardia (SVT) during pregnancy can be troublesome. Antiarrhythmic drugs (especially beta-blockers and calcium channel blockers) are frequently used for treatment of symptomatic patients. ...